Additional file 1: of HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors

Flow chart summarizing sample size and available data for the TCGA, Metabric and USO1062 cohort; Clinical metadata, subtype information, HER2A status, AR-ness score, HER2 copy number, and expression levels of ERBB2, ER, PR and AR for the tumors in these three cohorts. (XLSX 669 kb)